Elipovimab,Abbexa,abx831514
Elipovimab is a monoclonal antibody biosimilar expressed in CHO cells, targeting HIV-1 gp120, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Elipovimab (formerly GS-9722;PGT121-derived broadly neutralizing antibody).
Host
Human
Reactivity
Human
Application
ELISA, WB
Conjugate
Unconjugated
Platform ID
BAB357267035
Abbexa
Contact
Tel: +44 (0) 1223 755950
Fax: +44 (0) 1223 755951
Email:
Product Specifications
Specifications
NameElipovimab
Cat. No.abx831514
HostHuman
IsotypeIgG1 Lambda
ReactivityHuman
ConjugationUnconjugated
ApplicationELISA, WB
Working DilutionsOptimal dilutions/concentrations should be determined by the end user.
ClonalityMonoclonal
ConcentrationBatch-dependent, typically between 0.5-2.0 mg/ml.
TargetHIV-1 gp120
PurityPurified from cell culture supernatants by Protein A/G chromatography.
Appearance/FormLiquid
Formulation0.01 M PBS. pH 7.4.
StorageAliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Regulatory StatusResearch Use Only
Category Paths
- Products>Primary Antibodies>Biosimilar Antibodies
Request a product
Please provide the required information below so that we can quickly source your products.